Clinical And Morphological Improvement Of Lupus Nephritis Treated With Rituximab

Affiliations

Tsanyan Maria E.: Nasonova Research Institute of Rheumatology, Russian Academy of Science, Moscow, Russia
Soloviev Sergey K.: Nasonova Research Institute of Rheumatology, Russian Academy of Science, Moscow, Russia
Radenska-Lopovok Stefka G.: Nasonova Research Institute of Rheumatology, Russian Academy of Science, Moscow, Russia
Torgashina Anna V.: Nasonova Research Institute of Rheumatology, Russian Academy of Science, Moscow, Russia
Nikolaeva Ekaterina V.: Nasonova Research Institute of Rheumatology, Russian Academy of Science, Moscow, Russia
Khrennikov Yaroslav B.: Nasonova Research Institute of Rheumatology, Russian Academy of Science, Moscow, Russia
Nasonov Evgeniy L.: Nasonova Research Institute of Rheumatology, Russian Academy of Science, Moscow, Russia

Abstract

Aim: TO assess the effects of rituximab (RTM) therapy on clinical and morphologic activity of lupus nephritis (LN).